4D Molecular Therapeutics logo

4D Molecular Therapeutics

FDMT | NASDAQ
Chart Builder DCF Calculator
$11.29
-$0.94 (-7.69%)
At close: Nov 16, 2026, 4:00 PM ET
$11.29
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-7.69%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
40.8
+6.0 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #498/1021 (Top 49%)

Key Statistics

Market Data

Market Cap $815.72M
1D Range
11.22 12.34
52W Range
7.19 16.76

Valuation (TTM)

PE -4.05
PB 2.41
EV/EBITDA -2.66

Valuation (NTM)

Forward PE N/A
Forward PEG -0.15
Price Target $32.00
Loading financial charts...

Profile

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's d...

Sector Healthcare
Industry Biotechnology
Employees 196
IPO Date Dec 11, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 12, 2026
EPS
-$1.08
Miss -2.86%
REV
$4.14M
Beat +0.28%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$32.00
Upside
+183.44%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.